Ionis Pharmaceuticals, Inc.

IONS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008
Operating Activities
Net Income $155.1M $-18.2M
Depreciation & Amortization — —
Depreciation $3.9M $2.9M
Amortization — —
Stock-Based Compensation $13.4M $15.1M
Net Cash from Operating Activities $-108.4M $212.0M
Investing Activities
Capital Expenditures $13.4M $13.7M
Business Acquisitions — —
Net Cash from Investing Activities $-212.3M $-234.2M
Financing Activities
Dividends Paid — —
Stock Repurchases — —
Net Cash from Financing Activities $202.0M $107.6M
Net Change in Cash $-118.7M $85.4M
Free Cash Flow $-121.9M $198.4M
← Newer Page 3 of 3 Older →